Comparative Cardiovascular Safety of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer Using Real-World Data

医学 前列腺癌 危险系数 内科学 队列 雄激素剥夺疗法 肿瘤科 入射(几何) 置信区间 恩扎鲁胺 癌症 醋酸阿比特龙酯 雄激素受体 光学 物理
作者
Jason Hu,Armen Aprikian,Marie Vanhuyse,Alice Dragomir
出处
期刊:Clinical Genitourinary Cancer [Elsevier BV]
卷期号:20 (1): 17-24 被引量:22
标识
DOI:10.1016/j.clgc.2021.08.009
摘要

Novel hormonal agents (NHAs) such as abiraterone acetate (ABI) and enzalutamide (ENZ) are frequently used in metastatic castration-resistant prostate cancer (mCRPC). Despite their overall tolerable risk profile, certain signals of cardiovascular toxicity were reported for these agents in clinical trials but little is known about their incidence in clinical practice. The objective was to assess the comparative cardiovascular safety of ABI and ENZ in patients with mCRPC in the real-world.A retrospective population-based cohort was extracted from Quebec public healthcare administrative databases. First-time NHA users between 2011 and 2016 were selected. The primary outcome of interest was cardiovascular-related hospitalization (composite outcome that included acute coronary syndrome, cerebrovascular stroke, heart failure, arrhythmia and others). Inverse probability of treatment weighting (IPTW) with the propensity score was used to adjust for measured baseline characteristics including pre-existing cardiovascular disease.The cohort comprises 2,183 patients, with 1,773 (81.2%) in the ABI group and 410 (18.8%) in the ENZ group. Crude incidence rates of cardiovascular-related hospitalization were of 9.8 events per 100 person-years (PYs) and of 7.1 events per 100 PYs for the ABI and ENZ groups, respectively. The ABI group was at greater risk of cardiovascular-related hospitalization compared to the ENZ group (IPTW-hazard ratio (HR) 1.82; 95% confidence interval (95%CI) 1.09-3.05). The risk of hospitalization for heart failure was greater in ABI (IPTW-HR 2.88; 95%CI 1.09-7.63).Our findings suggest that ABI users may be at greater risk of cardiovascular-related hospitalization compared to ENZ users, in particular for heart failure. These results provide clinicians with additional insight on the cardiovascular risks of mCRPC patients treated with NHAs in the real-world and further large studies are required to corroborate these findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
3秒前
6秒前
传奇3应助wujiwuhui采纳,获得10
8秒前
开心寄松完成签到,获得积分10
10秒前
北宫完成签到 ,获得积分10
10秒前
wansida完成签到,获得积分10
14秒前
QXS完成签到 ,获得积分10
14秒前
15秒前
菠萝完成签到 ,获得积分10
15秒前
领导范儿应助Villanellel采纳,获得10
19秒前
wintersss完成签到,获得积分10
19秒前
尹尹发布了新的文献求助10
20秒前
量子星尘发布了新的文献求助10
22秒前
zzzzzz完成签到 ,获得积分10
26秒前
坦率的枕头完成签到,获得积分10
26秒前
XS_QI完成签到 ,获得积分10
26秒前
与共发布了新的文献求助10
29秒前
苑阿宇完成签到 ,获得积分10
29秒前
yck1027完成签到,获得积分10
30秒前
fatcat完成签到,获得积分10
30秒前
斯文败类应助Camus采纳,获得10
31秒前
33秒前
Tammy完成签到 ,获得积分10
33秒前
Herisland完成签到 ,获得积分10
35秒前
lulalula完成签到,获得积分10
36秒前
NEO完成签到 ,获得积分10
38秒前
zcydbttj2011完成签到 ,获得积分10
40秒前
温暖的小鸭子完成签到,获得积分10
42秒前
46秒前
王泽厚发布了新的文献求助20
47秒前
雪花发布了新的文献求助10
49秒前
周全完成签到 ,获得积分10
53秒前
water应助科研通管家采纳,获得10
54秒前
Owen应助科研通管家采纳,获得10
54秒前
内向忆南完成签到,获得积分10
57秒前
翱翔者完成签到 ,获得积分10
1分钟前
kryptonite完成签到 ,获得积分10
1分钟前
月军完成签到,获得积分10
1分钟前
欢呼寻冬完成签到 ,获得积分10
1分钟前
西安浴日光能赵炜完成签到,获得积分10
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038066
求助须知:如何正确求助?哪些是违规求助? 3575779
关于积分的说明 11373801
捐赠科研通 3305584
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022